Global Herpes Market is growing due to surging volume of herpes patients as there is high prevalence of herpes infections. Increasing geriatric population and rising collaborations among players are further propelling the growth of the market. However, product recalls may hamper the growth of the market.
Global Herpes Market Scenario
According to Data Bridge Market Research, the market for global herpes market in Asia-Pacific region has the highest market share. Market leaders are GlaxoSmithKline plc, Viatris Inc., and Fresenius Kabi AG which account for an estimated market share of approximately 55% to 60%. These companies have gained outstanding sale through providing medical device sterilization.
For instance:
- In November 2019, Mylan N.V. announced the combination of the company with Upjohn, a division of Pfizer. The new company formed would be named Viatris. The merger of both the companies to develop a combined firm has expanded its product portfolio, leading to increased demand for its product.
- In September 2018, Avet Pharmaceuticals Inc. announced the immediate availability of Acyclovir 200 mg capsules. This launch enhanced Avet’s broad portfolio of generic oral solid products. This new drug launched by the company has increased its sales and demand in the market, leading to increased revenue in the future.
Trends Impacting the Market
Now the question is, which other regions GlaxoSmithKline plc, Viatris Inc., and Fresenius Kabi AG are targeting? Data Bridge Market Research has estimated a large growth in North America herpes market and the market leaders targeting the U.S., Canada, and Mexico to be their next revenue pockets for 2020.
The global herpes market is becoming more competitive with companies, such as GlaxoSmithKline plc, Viatris Inc., Fresenius Kabi AG Pfizer Inc., Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.), and Abbott. Ltd, as they are the top dominating companies in the market, having maximum number of products. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global herpes market.
For more analysis on the global herpes market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-herpes-market
Global Herpes Market Development
- In August 2017, Glenmark Pharmaceuticals Inc., USA (Glenmark) was granted final approval by the United States Food & Drug Administration (U.S. FDA) for Acyclovir Ointment USP, 5%, the generic version of Zovirax Ointment, 5%, of Valeant International Bermuda. This approval has increased the credibility of the company in the market.
Scope of Global Herpes Market
Global herpes market is segmented on the basis of regions into North America, Europe, Asia-Pacific, South America, and Middle East and Africa. These regions are further segmented into major countries including the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Austria, Sweden, Belgium, Estonia and Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific, South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of Middle East and Africa, Brazil, Argentina and Rest of South America
- On the basis of virus type, the global herpes market is segmented into herpes simplex and herpes zoster.
To know more about the study https://www.databridgemarketresearch.com/reports/global-herpes-market
Key Pointers Covered in Global Herpes Market Industry Trends and Forecast to 2028
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
Key Market Competitors Covered in the Report
The key market players for Global Herpes Market are listed below:
- Abbott
- Apotex, Inc.
- Avet Pharmaceuticals, Inc.
- Bausch Health Companies, Inc.
- Cipla, Inc.
- Dr. Reddy’s Laboratories Ltd.
- EPI Health
- Fresenius Kabi AG
- GlaxoSmithKline plc.
- Glenmark Pharmaceutical Inc.
- USA, Maruho Co.,Ltd.
- Mylan N.V.
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Zydus Pharmaceuticals, Inc.
- RECORDATI S.p.A.
- Aurobindo Pharma
- Amneal Pharmaceuticals LLC
- Slavia Pharm S.R.L.
- Blistex, Inc.
Above are the key players covered in the report, to know about more and exhaustive list of Global Herpes Market companies, contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-herpes-market
Research Methodology: Global Herpes Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Clinicians, Healthcare Professionals, Researchers, Academician.
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Related Reports
- Global Viral Inactivation Market
- Global Viral Clearance Market
- Global Antiviral Drugs Market
- Global Hepatic Antiviral Drugs Market
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
